CQC Case Study: Ampersand’s MyIBD Care – Home Monitoring for Patients with IBD
Posted on 05 Aug 2019
The CQC is the independent regulator of health and social care in England. Their purpose is to make sure people are provided with safe, effective, and high-quality care. They have recently published a series of case studies about driving improvement through technology and MyIBD Care has been selected as a new Telemonitoring technology.
Are symptom tracker apps the future of healthcare?
25 Aug 2020
As part of the FutureOfHealthcare report published in the Times, Raconteur explores in this article explosion and acceptance of symptom tracker apps such as...
Digitally Enabled Care in Focus as NHS selects Ampersand Health for DigitalHealth.London Accelerator
09 Sep 2019
Digi-Tech Pharma & AI Conference 2021
11 Feb 2021
We are attending the 4th Annual Digi-Tech Pharma & AI Conference this year in May.
Press Release: London NHS CCGs Discuss Benefits of Using New HealthSuite App from Ampersand
19 Jul 2018
Clinical Commissioning Groups (CCGs) from across London have expressed interest in trialling and adopting digital self-management platform HealthSuite from...
Press Release: The Rheumatology Network for Dorset x My Arthritis app
15 Dec 2021
Ampersand Health has today announced a partnership with Our Dorset Digital and Rheumatology Dorset to roll out My Arthritis App across the county,...
